HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Europe Bans Preservative Mixture MCI/MI In Leave-On Cosmetics

This article was originally published in The Rose Sheet

Executive Summary

By July 16, 2015, cosmetics manufacturers will be prohibited from marketing leave-on products in Europe that contain a preservative mixture of methylchloroisothiazolinone and methylisothiazolinone under a ban the Cosmetic Ingredient Review Expert Panel anticipated with concern in recent meetings. Simultaneously, the EC announces stricter limits on propylparaben and butylparaben in personal-care items.

You may also be interested in...

CIR Expert Panel Affirms Safety Of Preservative MI, Reaches Decisions On Five Ingredients From Nature

At their 8-9 June meeting, CIR’s independent experts tentatively found methylisothiazolinone safe for use in rinse-off cosmetic products up to 100 ppm and safe in leave-on cosmetic products when formulated to be non-sensitizing, maintaining their more tolerant position on the preservative compared with the EU. More results.

CIR Expert Panel Finds MCI/MI Preservative Combo Safe With Caveats

CHART: At their December meeting, the Cosmetic Ingredient Review’s toxicology experts finalized four ingredient reports and issued five tentative safety assessments, plus four insufficient data announcements. The Expert Panel’s MCI/MI decision essentially upholds its 1992 stance on the preservative mixture, while highlighting its sensitization potential.

CIR Expert Panel’s 151st Meeting Marked By High Preservatives Content

Parabens, polyaminopropyl biguanide, imidazolidinyl urea and combination methylisothiazolinone/methylchloroisothiazolinone (MI/MCI) all came under scrutiny at the CIR Expert Panel’s June 6-7 meeting. HBW Insight discusses the mixed results and provides a full table of panel findings.

Related Content

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts